BioLife Solutions, Inc. (BLFS) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | 82.42M USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 447.49M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $0.00 | (m) | (m) | $82.42M | $447.49M | (m) |
| 2026-03-31 | (m) | (m) | $2.50M | (m) | (m) | $81.00M | $400.91M | (m) |
| 2025-12-31 | (m) | (m) | $5.00M | $0.00 | (m) | $88.93M | $405.88M | (m) |
| 2025-09-30 | (m) | (m) | $7.49M | $0.00 | (m) | $78.95M | $392.08M | (m) |
| 2025-06-30 | (m) | (m) | $10.05M | $0.00 | (m) | $81.77M | $387.24M | (m) |
| 2025-03-31 | (m) | (m) | $10.45M | $2.50M | (m) | $88.58M | $395.14M | (m) |
| 2024-12-31 | (m) | (m) | $10.94M | $5.00M | (m) | $104.58M | $399.49M | (m) |
| 2024-09-30 | (m) | (m) | $12.23M | $7.82M | (m) | $34.19M | $381.65M | (m) |
| 2024-06-30 | (m) | (m) | $10.61M | $10.45M | (m) | $34.13M | $374.98M | (m) |
| 2024-03-31 | (m) | (m) | $8.62M | $15.68M | (m) | $45.27M | $401.60M | (m) |
| 2023-12-31 | (m) | (m) | $6.83M | $18.31M | (m) | $51.70M | $412.71M | (m) |
| 2023-09-30 | (m) | (m) | $5.03M | $20.94M | (m) | $41.03M | $411.15M | (m) |
| 2023-06-30 | (m) | (m) | $1.94M | $23.57M | (m) | $46.26M | $433.18M | (m) |
| 2023-03-31 | (m) | (m) | $1.25M | $23.69M | (m) | $54.88M | $446.47M | (m) |
| 2022-12-31 | (m) | (m) | $1.81M | $23.79M | (m) | $62.70M | $450.23M | (m) |
| 2022-09-30 | (m) | (m) | $2.07M | $24.21M | (m) | $61.62M | $487.68M | (m) |
| 2022-06-30 | (m) | (m) | $1.36M | $6.19M | (m) | $46.55M | $470.38M | (m) |
| 2022-03-31 | (m) | (m) | $557.00K | $6.31M | (m) | (m) | $544.01M | (m) |
| 2021-12-31 | (m) | (m) | $862.00K | $6.35M | (m) | (m) | $554.06M | (m) |
| 2021-09-30 | (m) | (m) | $1.77M | $6.12M | (m) | (m) | $559.39M | (m) |
| 2021-06-30 | (m) | (m) | $2.92M | $5.02M | (m) | (m) | $520.97M | (m) |
| 2020-12-31 | (m) | (m) | $614.00K | $655.00K | (m) | (m) | $234.83M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |